Skip to main content

Is Wixela Inhub the same as Advair Diskus?

Medically reviewed by Drugs.com. Last updated on Sep 2, 2024.

How does Wixela Inhub compare to Advair Diskus in price?

Official answer

by Drugs.com

Wixela Inhub is the first approved generic version of Advair Diskus. It is therapeutically equivalent to Advair Diskus.

Wixela Inhub and Advair Diskus (fluticasone propionate and salmeterol inhalation powder, USP) are combination products containing a corticosteroid and a long-acting beta2-adrenergic agonist indicated for:

Wixela Inhub and Advair Diskus are NOT indicated for relief of acute bronchospasm.

Both Wixela Inhub and Advair Diskus are supplied as inhalers containing powder for inhalation in the following strengths:

  • fluticasone propionate 100 mcg and salmeterol 50 mcg
  • fluticasone propionate 250 mcg and salmeterol 50 mcg
  • fluticasone propionate 500 mcg and salmeterol 50 mcg

Advair Diskus was first approved by the FDA in August 2000.
Wixela Inhub was first approved by the FDA in January 2019.

Generic products in general provide significant cost savings compared to the brand name product.

For more information on pricing see:

Related questions

Read next

Is Symbicort a steroid inhaler?

Symbicort contains an inhaled corticosteroid (“steroid”) known as budesonide to reduce inflammation in the lungs, but also contains a medicine known as formoterol. Formoterol is a long-acting inhaled bronchodilator that relaxes muscles in the airways to improve breathing. Continue reading

What foods should be avoided with COPD?

In some people, certain foods have been noted to aggravate symptoms of chronic obstructive pulmonary disease (COPD). These types of foods include: fried foods, carbonated beverages, excessively salty food or too much added salt, some dairy products, cruciferous vegetables (for example: kale, broccoli, cabbage) and preserved meats and cold cuts (with nitrates). Continue reading

What are the 4 stages of COPD?

COPD is now classified using grades, not stages. Grades of COPD are ranked from 1 to 4, ranging from mild to a very severe grade of lung disease based on your results from a breathing test called spirometry. Your healthcare provider may place you into a group (A to D) based on your current symptoms and your chances for flare-ups and hospitalizations. Continue reading

Related medical questions

Drug information

Related support groups